PBYI - Puma Biotechnology Inc Stock - Stock Price, Institutional Ownership, Shareholders (NASDAQ)
Puma Biotechnology, Inc. (PBYI) Stock Price, Quote, News & Analysis
PBYI Stock Price and Chart — NASDAQ:PBYI — TradingView
Puma (PBYI): Recent Rally Looks Overdone, Unsupported With Fundamentals | Seeking Alpha
Shareholder Class Action Filed Against Puma Biotechnology, Inc. | New Cases | Kessler Topaz
Puma Biotechnology's (PBYI) 52 Week High at $5.08 & Low at $2.14
Transcript : Puma Biotechnology, Inc., Q2 2023 Earnings Call, Aug 03, 2023 -August 03, 2023 at 04:30 pm EDT | MarketScreener
pbyi-10k_20171231.htm
Puma Biotechnology (PBYI) Price Target Increased by 5.26% to 5.10
Federal Jury Awards Puma Biotechnology Investors Damages in Securities Class-Action Verdict - Los Angeles Business Journal
Puma Biotechnology Stock Forecast: down to 0.000001 USD? - PBYI Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis
Is Puma Biotechnology (PBYI) Stock a Solid Choice Right Now?
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | The Motley Fool
Puma Biotechnology - Updates, News, Events, Signals & Triggers
PBYI - Puma Biotechnology Inc Stock - Stock Price, Institutional Ownership, Shareholders (NASDAQ)
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Puma Biotechnology Stock Forecast: down to 0.000001 USD? - PBYI Stock Price Prediction, Long-Term & Short-Term Share Revenue Prognosis with Smart Technical Analysis
Puma Biotechnology, Inc. (NASDAQ:PBYI) Held Back By Insufficient Growth Even After Shares Climb 34%
PBYI Stock Price and Chart — NASDAQ:PBYI — TradingView
Puma Biotechnology Surpasses Expectations with Impressive Q2 Financial Results - Best Stocks
Puma Biotechnology Announces FDA Clearance of IND for Alisertib in Small Cell Lung Cancer
Puma Biotechnology Reports Fourth Quarter and Full Year Financial Results | Business Wire
